Literature DB >> 24011398

Types and sociodemographic correlates of complementary and alternative medicine (CAM) use among people with epilepsy in Oman.

Abdullah Al Asmi1, Abdullah Al Maniri, Yahya M Al-Farsi, David T Burke, Fatema M H Al Asfoor, Ibrahim Al Busaidi, Mohamed H A Al Breiki, Shaon Lahiri, Nady Braidy, Musthafa M Essa, Samir Al-Adawi.   

Abstract

Nonpharmacological treatment strategies that originate from sociocultural teachings and are beyond the scope of allopathic medicine are commonly used among people with epilepsy (PWE) in many parts of the world. The present study explored the types and sociodemographic correlates of complementary and alternative medicine (CAM) use among PWE in Oman among attendees of a neurological unit at a tertiary care center. Data on the types of CAM were gathered from telephone interviews. The relevant demographic and clinical characteristics of the participants were obtained from electronic medical records. Of the total of 101 participants, 73.3% were CAM users. The majority of these participants have not disclosed their CAM use to their allopathic health-care providers. The most common types of CAM reported were those falling under the 'mind-body' type (incantations and fumigation) and biologically based (herbal concoctions) or a combination of them. Compared to non-CAM users, a significant and greater proportion of CAM users attributed the etiology of their illness to nonbiomedical factors such as 'evil eyes' (P=0.04). The multivariate logistic regression model indicated that the use of CAM was highly associated with age of <30years (OR=3.09; 95% CI: 1.10, 5.46), unemployment (OR=2.04; 95% CI: 1.15, 6.39), having basic school education (OR=2.21; 95% CI: 0.83, 5.18), low family income (OR=1.52; 95% CI: 0.91, 2.11), and the presence of hypersalivation (OR=2.20; 95% CI: 1.01, 4.39). Further studies are needed to harmonize these two healing practices. On the whole, this study indicates that among attendees of tertiary care utilization, CAM is common among PWE in Oman. The most utilized type of CAM falls under the umbrella of mind-body practice.
© 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Arab/Islamic; Complementary and alternative medicine; Oman; People with epilepsy; Tertiary care

Mesh:

Year:  2013        PMID: 24011398     DOI: 10.1016/j.yebeh.2013.07.022

Source DB:  PubMed          Journal:  Epilepsy Behav        ISSN: 1525-5050            Impact factor:   2.937


  7 in total

1.  Mental Health Services in Oman: The Need for More Cultural Relevance.

Authors:  Samir Al-Adawi
Journal:  Oman Med J       Date:  2017-03

2.  Adverse Effects of Medicines: Is the Omani population safe?

Authors:  Muna Al-Saadoon
Journal:  Sultan Qaboos Univ Med J       Date:  2015-05-28

3.  Use of complementary and alternative medicines in haemodialysis patients: a cross-sectional study from Palestine.

Authors:  Sa'ed H Zyoud; Samah W Al-Jabi; Waleed M Sweileh; Ghada H Tabeeb; Nora A Ayaseh; Mayas N Sawafta; Razan L Khdeir; Diana O Mezyed; Dala N Daraghmeh; Rahmat Awang
Journal:  BMC Complement Altern Med       Date:  2016-07-11       Impact factor: 3.659

Review 4.  Recent Advances in Antiepileptic Herbal Medicine.

Authors:  Stephen M Manchishi
Journal:  Curr Neuropharmacol       Date:  2018       Impact factor: 7.363

5.  Impact of complementary and alternative medicines on antiepileptic medication adherence among epilepsy patients.

Authors:  Muhammad Junaid Farrukh; Mohd Makmor-Bakry; Ernieda Hatah; Tan Hui Jan
Journal:  BMC Complement Med Ther       Date:  2021-02-04

6.  Cognitive profiles in patients with multi-infarct dementia: an omani study.

Authors:  Samir Al-Adawi; Nady Braidy; Musthafa Essa; Faisal Al-Azri; Samir Hussain; Nasser Al-Sibani; Jabar Al-Khabouri; Abdullah Al-Asmi; Ali Al-Mashani
Journal:  Dement Geriatr Cogn Dis Extra       Date:  2014-07-18

Review 7.  Use of complementary and alternative medicine and adherence to antiepileptic drug therapy among epilepsy patients: a systematic review.

Authors:  Muhammad Junaid Farrukh; Mohd Makmor-Bakry; Ernieda Hatah; Hui Jan Tan
Journal:  Patient Prefer Adherence       Date:  2018-10-11       Impact factor: 2.711

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.